Validation of a genomic classifier that predicts metastatic disease progression in men with high-risk pathologic features postprostatectomy.

Authors

null

Mercedeh Ghadessi

GenomeDx Biosciences Inc., Vancouver, BC, Canada

Mercedeh Ghadessi , Eric J. Bergstralh , Nicholas Erho , Anamaria Crisan , Elai Davicioni , Christine Buerki , Anirban Pradip Mitra , Darby J. S. Thompson , Rachel Carlson , Zaid Haddad , Benedikt Zimmermann , Karla V. Ballman , Thomas M. Kollmeyer , Thomas Sierocinski , Ismael A. Vergara , Timothy J. Triche , Peter C. Black , R. Houston Thompson , R. Jeffrey Karnes , Robert B. Jenkins

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2013 Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

General Poster Session A: Prostate Cancer

Track

Prostate Cancer

Sub Track

Prostate Cancer

Citation

J Clin Oncol 31, 2013 (suppl 6; abstr 36)

DOI

10.1200/jco.2013.31.6_suppl.36

Abstract #

36

Poster Bd #

C9

Abstract Disclosures

Similar Posters